News |
← |
|
Ferentis UAB is participating in a new project BIOACTION
2023 07 26 Ferentis UAB is participating in a new project BIOACTION, funded by the European Innovation Council’s Pathfinder Open. The project focuses on hydrogel technologies with the aim to turn the bacteria biofilm into a bio-factory for tissue regeneration. More details |
|
FERENTIS TO CONDUCT A NEW PROJECT ON HUMAN CORNEA TRANSPLANTATION MODEL, SYNTHESIZED FROM BIOLOGICALLY ACTIVE COLLAGEN PEPTIDE SEQUENCES (BIOCORNEA)
2020 09 10 FERENTIS TO CONDUCT A NEW PROJECT ON HUMAN CORNEA TRANSPLANTATION MODEL, SYNTHESIZED FROM BIOLOGICALLY ACTIVE COLLAGEN PEPTIDE SEQUENCES (BIOCORNEA) More details |
|
FERENTIS TO CONDUCT A NEW PROJECT ON BIOSYNTHETIC MATERIALS FOR TISSUE-ON-A-CHIP TECHNOLOGIES
2018 08 10 UAB Ferentis has been awarded a new grant under the program foreseen for supporting R&D at companies. More details |
|
2018 06 06 Ferentis is pleased to announce that its UK patent was granted for the invention entitled "Collagen Mimetic Peptide". More details |
|
Ferentis participated in top level Japan-Lithuania business forum
2018 01 13 On the occasion of the visit of the Japanese Prime Minister Shinzo Abe to Lithuania on January 13, 2018, Ferentis Business Development Director participated in the business forum hosted by the Government Office of the Republic of Lithuania. More details
|
|
Ferentis granted European patent for Regenerative Prostheses as Alternatives to Donor Corneas for Transplantation
2018 01 08 On 2018.01.05 the European Patent Office granted Ferentis the European patent for its Regenerative Prostheses as Alternatives to Donor Corneas for Transplantation. More details
|
|
EuroNanomed2 R&D project involving Ferentis
2017 10 16 The results of the ongoing REGENERATE project, which also involves Ferentis as a partner, have been reported by Healio.com, an in-depth specialty clinical information website. The project team is developing a novel regenerative medicine and tissue engineering method to treat the limbal epithelial stem cells deficiency of the eye cornea by employing Ferentis’ synthetic collagen mimetic peptide (CMP) hydrogel technology as one of the possible platforms. More details
|
|
Ferentis to participate in BioJapan 2016
2016 10 04 Sept. 30, 2016. Ferentis will participate in BioJapan 2016. We will be present in the booths of two exhibitors: our distribution partner Tokyo Future Style (Booth No. A-29) and Enterprise Lithuania (Booth No. B-71). We are also registered in the Partnering System. We look forward to meeting new customers and partners in Japan! More details
|
|
Ferentis Signs Japan Distribution Agreement with Tokyo Future Style
2016 06 08 June 06, 2016. Vilnius, Lithuania. Ferentis and Tokyo Future Style are pleased to announce having signed an agreement for distribution of Ferentis’ proprietary self-assembling peptide-based hydrogel products throughout Japan. More details
|
|
Ferentis at Biotech Japan 2016
2016 05 02 On May 10-13 Ferentis will be among the Exhibitors at Biotech Japan2016, Booth No.6-39. See you at the show! More details
|
|
Swedish Royals visit Ferentis
2015 10 08 Swedish royal couple visited Ferentis today as part of their visit to the CPST Science and Technology Park. Our co-founder Dr. Ramunas Valiokas presented our company to King Carl XVI Gustaf and Queen Silvia of Sweden. More details
|
|
Ferentis successfully completes EU funded R&D infrastructure project
2015 10 01 UAB „Ferentis“ has successfully completed a project UAB „Ferentis“ completed a project “Development of Ferentis scientific research infrastructure“, which was jointly financed from the European Regional Development Fund, available through the 2007–2013 Economic Growth Operational Programme. More details
|
|
Ferentis successfully completes EU financed project
2015 09 30 Ferentis has successfully completed a project titled „Development of synthetic matrix for tissue on a chip in vitro models“, which was jointly financed from the European Regional Development Fund, available through the 2007–2013 Economic Growth Operational Programme. More details
|
|
Ferentis awarded EU Eurostars funding
2015 09 28 2015-09-28 Vilnius. Ferentis UAB, Experimentica Ltd. (Finland), and State Research Institute Center for Physical Sciences and Technology (Lithuania), were awarded funding from the Eurostars programme to develop synthetic human-like corneal models as in vitro tools to aid eye drug assessment and screening, and reduce animal testing. More details
|
|
Ferentis selected for European Commission‘s SME Instrument Grant
2015 01 03 Ferentis‘ BIOTIMA project has been selected by the European Commission in second round of calls, to join the SME Instrument (Phase 1) Horizon 2020 programme of the European Union. More details
|
|
Ferentis - a member of the winning project consortium within the EuroNanoMed2 program
2014 10 12 Vilnius, 2014-10-12. As part of the consortium, Ferentis will participate in the research project REGENERATE, which is targeted at developing a novel regenerative medicine and tissue engineering method to treat the limbal epithelial stem cells deficiency (LSCD) of eye cornea. The winning project is funded by the EU ERA-NET program EuroNanoMed2. More details
|
|
Ferentis selected winner of Life Sciences Baltics 2014 Startup Event
2014 09 11 Ferentis was selected by a panel of judges as the winner of Life Sciences Baltics 2014 Conference Startup Event More details
|
|
Ferentis named Best New Company at European Life Science Awards 2014
2014 05 14 Ferentis was announced to be the winner in the category of Best New Company 2014 at the 4th Annual European Life Science Awards that were held in Barcelona, Spain. More details
|
|
Project led by Ferentis founders – winner of the Nanomedicine Award at BIO-Europe
2013 11 05 Vienna, November 4th, 2013 – A group led by two Ferentis founders, Prof. May Griffith, of Linköping University (Project coordinator) and Dr. Ramunas Valiokas from the Centre for Physical Sciences and Technology (Lithuanian Partner), received the Nanomedicine Award in the regenerative medicine category at the Nanomedicine Panel at BIO-Europe conference in Vienna, November 4th 2013. More details
|
|
Ferentis wins two research grants
2013 10 16 UAB Ferentis was awarded two research and development grants funded by EU structural funds and Lithuanian government through Intelektas LT and Intelektas LT+ programs. The first grant, amounting to EUR 160 thousand will fund the project “Synthetic matrix for tissue-on-a-chip in vitro models”. The goal is to develop the basic set of materials and processes for assembly of cell culture-based devices that efficiently mimic the environment of biomaterials used in cosmetic, organ repair and regenerative medicine applications. The second grant, for a total of EUR 360 thousand, will fund the enhancement of the research laboratory capabilities of UAB “Ferentis”. More details
|
| ↑ | ← |